This study is conducted in Europe. The aim of the study is to gather information about hypoglycaemia (low blood glucose) among patients with Type 1 or Type 2 diabetes mellitus. The study is both retrospective and prospective.
Study Type
OBSERVATIONAL
Enrollment
29,304
Patients will be asked to complete a two-part patient self-assessment questionnaire (SAQ) comprising a retrospective cross-sectional evaluation (Part 1), and a prospective observational evaluation (Part 2).
Novo Nordisk Investigational Site
Prov. de Buenos Aires, Argentina
Incidence of any hypoglycaemic event
Time frame: In the 4 weeks prior to and following the baseline visit (Week 0)
Difference in the reported incidence rates of any hypoglycaemia
Time frame: In the 4 weeks prior to (Part 1) versus following (Part 2) the baseline visit
Incidence of hypoglycaemic events requiring hospital admission
Time frame: In the 6 months prior to and 4 weeks following the baseline visit
Incidence of all severe hypoglycaemic events
Time frame: In the 6 months prior to and 4 weeks following the baseline visit
Incidence of probable symptomatic hypoglycaemic events
Time frame: In the 4 weeks prior to and following the baseline visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novo Nordisk Investigational Site
Vienna, Austria
Novo Nordisk Investigational Site
Sofia, Bulgaria
Novo Nordisk Investigational Site
Mississauga, Canada
Novo Nordisk Investigational Site
Zagreb, Croatia
Novo Nordisk Investigational Site
Prague, Czechia
Novo Nordisk Investigational Site
Copenhagen S, Denmark
Novo Nordisk Investigational Site
Espoo, Finland
Novo Nordisk Investigational Site
Mainz, Germany
Novo Nordisk Investigational Site
Budapest, Hungary
...and 14 more locations